Mycophenolate Mofetil Monotherapy in Liver Transplantation
Authors:
- S. MirabellaSMS. Mirabella
- A. BrunatiABA. Brunati
- A. RicchiutiARA. Ricchiuti
- A. FranchelloAFA. Franchello
- M. SalizzoniMSM. Salizzoni
- 1 July 2005
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (6) , 2614-2615
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mycophenolate mofetil monotherapy in liver transplant recipients: A single center experienceLiver Transplantation, 2004
- Mycophenolate Mofetil Can Be Used as Monotherapy Late After Liver TransplantationAmerican Journal of Transplantation, 2004
- Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantationTransplantation Proceedings, 2003
- Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantationTransplantation, 2003
- Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failureTransplantation Proceedings, 2002
- Mycophenolate mofetil monotherapy in liver transplantationThe Lancet, 2001
- Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled studyThe Lancet, 2001
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994